RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28863969http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28863969http://www.w3.org/2000/01/rdf-schema#comment"Interleukin-7 is a cytokine essential for T cell homeostasis. IL-7 binds to cellular IL-7 receptors in competition with a soluble form of the receptor (sIL-7Rα). We hypothesized that altered sIL-7Rα levels may cause adverse outcomes in patients undergoing HSCT. In parallel, we investigated the impact of the IL-7Rα SNP rs6897932, which has been associated with release of IL-7R. The sIL-7Rα levels decreased during HSCT (from 114ng/ml before to 48ng/ml at day +14 (P<0.0001)). This pattern was inversely mirrored by IL-7. The IL-7/sIL-7Rα ratio at day +14 was significantly higher in patients developing grades II-IV aGVHD (OR=4.3, P=0.026). Furthermore, donor carriage of the rs6897932 T allele was associated with reduced sIL-7Rα levels, increased risk of grades II-IV aGVHD (OR=2.4, P=0.055) and increased transplant-related mortality (CC=4.5%, CT=21.4% and TT=27.3%, P=0.0037). In conclusion, this study suggests an impact of sIL-7Rα levels and rs6897932 donor genotype on alloreactivity and outcome after HSCT."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.org/dc/terms/identifier"doi:10.1016/j.clim.2017.08.015"xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Muller K."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Christensen I.J."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Ryder L.P."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Faucher S."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Yakoub-Agha I."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Shamim Z."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Decker W."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Thiant S."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/author"Kielsen K."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/name"Clin Immunol"xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/pages"26-32"xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/title"Soluble Interleukin-7 receptor levels and risk of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation."xsd:string
http://purl.uniprot.org/citations/28863969http://purl.uniprot.org/core/volume"187"xsd:string
http://purl.uniprot.org/citations/28863969http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28863969
http://purl.uniprot.org/citations/28863969http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28863969
http://purl.uniprot.org/uniprot/#_B8YG18-mappedCitation-28863969http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28863969
http://purl.uniprot.org/uniprot/#_F6IQ79-mappedCitation-28863969http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28863969
http://purl.uniprot.org/uniprot/#_F6IQ80-mappedCitation-28863969http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28863969
http://purl.uniprot.org/uniprot/#_P16871-mappedCitation-28863969http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28863969
http://purl.uniprot.org/uniprot/B8YG18http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28863969
http://purl.uniprot.org/uniprot/F6IQ80http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28863969